PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Although PNPLA3 has been shown to exhibit acyltransferase [118] as well as neutral lipid hydrolase activity [115,116,117,149], the underlying molecular mechanism for the strong NAFLD predisposition is presently unclear.